Duke University Medical Center
Durham, North Carolina, 27706, United States
Location status: Recruiting
NCT Number: NCT07089901
Tobacco use is a chronic relapsing condition. That is, even with state-of-the-art treatment, >70% of smoking cessation attempts end in a return to regular smoking. Research demonstrates that everyday environments associated with smoking trigger craving for cigarettes, provoke smoking, and lead to relapse. However, despite this knowledge, understanding of environmental correlates of smoking has been limited by a reliance on self-report, leading to imprecise information about the physical environments in which people live. To overcome this challenge, the research team has pioneered the development of digital envirotyping, which uses digital tools (e.g., sensors, cameras, artificial intelligence) to efficiently and accurately characterize and categorize environments with the goal of identifying environmental markers of behavior and health. Foundational to the digital envirotyping research is computer vision (CV), a type of artificial intelligence (AI) that enables computer systems to recognize objects and scenes in digital images, mimicking how humans perceive and understand visual information. With CV researchers can extract detailed and accurate information (i.e., objects and location types) about the everyday environments of people who smoke (PWS) and relate that information to smoking behavior. After validating the use of CV, the researchers used CV to develop enviromarkers of relapse risk. Importantly, they identified a novel enviromarker in which people at greater risk for relapse when they quit are exposed to a more consistent level of environment-related smoking risk as they move between their smoking and nonsmoking environments.
Research is now needed to advance digital envirotyping and enviromarker development in the field of tobacco addiction. The study will recruit a diverse, national sample of n=500 adults who are interested in quitting smoking. For two weeks prior to quitting, they will undergo photoEMA in which they will take two pictures of their current environment when they smoke, and randomly 10 times per day resulting in >300,000 images total. Cessation will be supported by nicotine replacement therapy (i.e., nicotine patch). The primary clinical outcome will be days to relapse. Specific aims are to (1) further develop, refine, and validate methods for efficient digital envirotyping at scale, (2) leverage CV and AI approaches to develop enviromarkers of smoking relapse, and (3) conduct analyses to increase understanding of environmental smoking risk in women and individuals with low socioeconomic status.
Interested in participating?
Request Info21 year and older
All sexes
Interventional
Phase 4
Durham, North Carolina, 27706, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All participants will receive transdermal nicotine replacement therapy (21 mg. patches)
Other names: NRT, nicotine patch
Time frame: From quit date to 6-month follow-up (about 6.5 months)
Participants will self-report smoking from quit date to the 6-month follow-up visit. Days to relapse will be defined as the first of seven consecutive days of smoking.
Time frame: 1-month follow-up (around 1.5 months after beginning treatment)
7-day point prevalence abstinence is defined as no smoking in the prior 7 days.
Time frame: 3-month follow-up (around 3.5 months after beginning treatment)
7-day point prevalence abstinence is defined as no smoking in the prior 7 days.
Time frame: 6-month follow-up (around 6.5 months after beginning treatment)
7-day point prevalence abstinence is defined as no smoking in the prior 7 days.
Contact information is provided by the study sponsor or research team.
Jasmin Walia
CONTACT
Laura Van Althuis, MHA
CONTACT
Duke University
Other
Acronym: DEDUCE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07166120
Behavior, Health Behavior
St Louis, Missouri, United States
View Trial DetailsNCT06991062
Behavior, Smoking
Houston, Texas, United States
View Trial DetailsNCT07223840
Behavior, Smoking
Rogers, Arkansas, United States
View Trial DetailsNCT07710820
Behavior, Smoking
Brandon, Florida, United States
View Trial Details